Announcements and Notices - [Other - Business Update]

Shanghai Fudan-Zhangjiang Bio-pharmaceutical Company Limited researches, develops, and sells self-developed bio-pharmaceutical know-how.  The Company also carries out contracted research for customers, manufactures and sells diagnostic reagent, and provides related ancillary services in China.

Indicative Announcement-Obeticholic Acid Tablets For The Treatment Of Primary Biliary Cholangitis Received The Acceptance Notice For The Abbreviated New Drug Application

Announcements and Notices - [Quarterly Results / Overseas Regulatory Announcement - Business Update / Inside Information]

The Third Quarterly Results Announcement For The Nine Months Ended 30 September 2024

Announcements and Notices - [Date of Board Meeting]

Notice Of Board Meeting

Announcements and Notices - [Discloseable Transaction]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Shanghai Fudan Zhangjiang H (1349 HK)

Indicative Announcement-Obeticholic Acid Tablets For The Treatment Of Primary Biliary Cholangitis Received The Acceptance Notice For The Abbreviated New Drug Application

The Third Quarterly Results Announcement For The Nine Months Ended 30 September 2024

Notice Of Board Meeting

Discloseable Transaction-Subscription Of Structured Deposit Product Under The Spd Bank

Discloseable Transaction-Subscription Of The Structured Deposit Product Under Ping An Bank

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)